Ioannis Kontopidis, MD | Rutgers Cancer Institute of New Jersey
Ioannis Papasotiriou | RGCC International GmbH, Switzerland | | Conferenceseries
Stem Cell 2019 - American College for Advancement in Medicine (ACAM)
RGCC Malaysia - Research Genetic Cancer Center
Stem Cell 2019 - American College for Advancement in Medicine (ACAM)
RGCC Malaysia - Research Genetic Cancer Center
Ioannis PAPASOTIRIOU | Managing Director | Molecular Medicine | Research profile
Stem Cell 2019 - American College for Advancement in Medicine (ACAM)
RGCC Malaysia - Research Genetic Cancer Center
The Allosteric Site on SHP2's Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules | ACS Omega
Meet Our Founder Dr. Ioannis | RGCC | North America
RGCC Malaysia - Research Genetic Cancer Center
Efficacy of 5-FU or Oxaliplatin Monotherapy over Combination Therapy in Colorectal Cancer
DC Maturation: A Brief Comparison between Three Different Processes
Stem Cell 2019 - American College for Advancement in Medicine (ACAM)
Francesco MASEDU | Professor | Mathematics, Biostatistcs PhD | Università degli Studi dell'Aquila, L'Aquila | Università dell'Aquila | Department of Biotechnological and Applied Clinical Sciences | Research profile
Ioannis PAPASOTIRIOU | Managing Director | Molecular Medicine | Research profile
Meet Our Founder Dr. Ioannis | RGCC | North America
Γιαμούζης Γρηγόριος – ΠΜΣ: Διαγνωστική και Θεραπευτική Προσέγγιση του Διαβητικού Ποδιού
Dr Ioannis Papasotiriou - Chief Executive Officer at RGCC | The Org
The Allosteric Site on SHP2's Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules | ACS Omega
Dr Ioannis Papasotiriou – Chief Executive Officer – RGCC | LinkedIn
